CONNOR GOLDEN: Open Payments
NPI 1720679871 · DUBUQUE, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$445 in 39 payments from 7 companies in 2025. Trend: 2023 $2,067 · 2024 $225 · 2025 $445
Food & beverage: $445
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 30 | $212 |
| Novartis Pharmaceuticals Corporation | 3 | $88 |
| ABBVIE INC. | 2 | $53 |
| Axsome Therapeutics, Inc. | 1 | $27 |
| Genentech USA, Inc. | 1 | $26 |
| Biogen, Inc. | 1 | $21 |
| AstraZeneca Pharmaceuticals LP | 1 | $19 |
Products named: NURTEC ODT, KESIMPTA, UBRELVY, Sunosi, Ocrevus Zunovo, VUMERITY, WAINUA.
Industry payments across IA — which companies pay providers there.
